Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ozturk, 1997, 226
Eker, 1999, 13
Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230
Dagli, 2009, Ghrelin expression in normal kidney tissue and renal carcinomas, Pathol Res Pract, 205, 165, 10.1016/j.prp.2008.10.002
Aydin, 2007, Discovery of ghrelin hormone: research and clinical applications, Turk. J. Biochem., 32, 76
Brunetti, 2002, Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus, Eur. J. Pharmacol., 454, 189, 10.1016/S0014-2999(02)02552-9
Hyttel, 1982, Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity, Prog. Neuropsychopharmacol. Biol. Psychiatry, 6, 277, 10.1016/S0278-5846(82)80179-6
Bezchlibnyk-Butler, 2000, Citalopram: a review of pharmacological and clinical effects, J. Psychiatry Neurosci., 25, 241
Träskman-Bendz, 1984, CSF monoamine metabolites of depressed patients during illness and after recovery, Acta Psychiatr. Scand., 69, 333, 10.1111/j.1600-0447.1984.tb02503.x
Sullivan, 2006, Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function, Biol. Psychiatry, 60, 500, 10.1016/j.biopsych.2005.11.022
Vaswani, 2003, Role of SSRI in psychiatric disorder, Prog. Neuropsychopharmacol. Biol. Psy., 27, 85, 10.1016/S0278-5846(02)00338-X
De Vriese, 2007, Ghrelin interacts with human plasma lipoproteins, Endocrinology, 148, 2355, 10.1210/en.2006-1281
Uriel, 1961, Characterization of cholinesterase and other carboxylic esterases after electrophoresis and immunoelectrophoresis on agar. I. Application to the study of esterases of normal human serum, Am. Instit. Pasteur., 101, 104
Mackness, 1985, The separation of sheep and human serum “A”-esterase activity into the lipoprotein fraction by ultracentrifugation, Comp. Biochem. Physiol. B., 82, 675, 10.1016/0305-0491(85)90506-1
Kumru, 2004, Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women, Eur. J. Obstet. Gynecol. Reprod. Biol., 114, 177, 10.1016/j.ejogrb.2003.10.023
Ng, 2001, Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein, J. Biol. Chem., 276, 44444, 10.1074/jbc.M105660200
Mackness, 1997, Alloenzymes of paraoxonase and effectiveness of high density lipoproteins in protecting low density lipoprotein against lipid peroxidation, The Lancet, 349, 851, 10.1016/S0140-6736(05)61755-2
La Du, 1999, On the physical role(s) of the paraoxonases, Chem-Biol. Inter., 14, 379, 10.1016/S0009-2797(99)00049-6
Paz, 2008, LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs, Clin. Biochem., 41, 1002, 10.1016/j.clinbiochem.2008.04.017
Palik, 2005, Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics, Diabetes Res. Clin. Pract., 68, 60, 10.1016/j.diabres.2005.03.008
1994
Eckerson, 1983, The human serum paraoxonase/arylesterase polymorphism, Am. J. Hum. Genet., 35, 1126
Haagen, 1992, A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate, Eur. J. Clin. Chem. Clim. Biochem., 30, 391
Horoz, 2007, PON1 status in haemodialysis patients and the impact of hepatitis C infection, Clin. Biochem., 40, 609, 10.1016/j.clinbiochem.2007.01.019
Cummings, 2006, Ghrelin and the short- and long-term regulation of appetite and body weight, Physiol. Behav., 89, 71, 10.1016/j.physbeh.2006.05.022
Tschöp, 2001, Circulating ghrelin levels are decreased in human obesity, Diabetes, 50, 707, 10.2337/diabetes.50.4.707
Ozdemir, 2009, Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 62, 10.1016/j.pnpbp.2008.10.004
El Eter, 2007, In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat, J. Gastroenterol. Hepatol., 22, 1791, 10.1111/j.1440-1746.2006.04696.x
Gur, 2007, Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers, Coron. Artery Dis., 18, 89, 10.1097/MCA.0b013e32801104e8
Sarandol, 2006, Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 1103, 10.1016/j.pnpbp.2006.04.012
Bauters, 2000, Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin, Circulation, 101, 740, 10.1161/01.CIR.101.7.740
Demirsoy, 2000, 795
Horsten, 1997, Depressive symptoms, social support, and lipid profile in healthy middleaged women, Psychosom. Med., 59, 521, 10.1097/00006842-199709000-00009
Maes, 1999, Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients, Psychiatry Res., 85, 275, 10.1016/S0165-1781(99)00014-1
Selvi, 2004, Postpartum depression and serum cholesterol level, Clinical Psychiatry, 7, 48
Agargun, 2002, Serum cholesterol concentration, depression, and anxiety, Acta Psychiatr. Scand., 105, 81, 10.1034/j.1600-0447.2002.1e002.x
Agargun, 2002, Sleep-related violence and low serum cholesterol: a preliminary study, Psychiatry Clin. Neurosci., 56, 195, 10.1046/j.1440-1819.2002.00954.x
Kirpinar, 1998, Serum cholesterol and triglyceride levels in depression, Turkish Journal of Psychiatry, 9, 23
McCallum, 1994, Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study, Aust. N. Z. J. Med., 24, 561, 10.1111/j.1445-5994.1994.tb01758.x
Oxenrug, 1983, Is serum cholesterol a biological marker for major depressive episode?, Am. J. Psychiatry, 140, 920, 10.1176/ajp.140.7.920
Yates, 1987, Cardiovascular risk factors in affective disorder, J. Affective Dis., 12, 129, 10.1016/0165-0327(87)90004-8
Sayar, 1998, Cholesterol levels in major depression, Bull. Clin. Psychopharmacol., 8, 104